Article Details

Regeneron's Best-Selling Eye Drug Eylea's Higher Dose Formulation Meets Primary Goal In ...

Retrieved on: 2024-12-17 18:10:35

Tags for this article:

Click the tags to see associated articles and topics

Regeneron's Best-Selling Eye Drug Eylea's Higher Dose Formulation Meets Primary Goal In .... View article details on hiswai:

Excerpt

Price Action: REGN stock is up 2.04% at $739.64 at the last check on Tuesday. Read Next: NXP Semiconductors Bets Big On Auto Connectivity With $242.5 ...

Article found on: www.benzinga.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up